Anti-UGT2A2 antibodies are used in the immunodetection of the protein UDP glucuronosyltransferase family 2 member A2. In humans, the canonical protein has a reported length of 536 amino acid residues and a mass of 60.8 kDa. Its subcellular localization is in the ER. Up to 2 different isoforms have been reported for this protein. It is reported to be mainly expressed in the nasal mucosa. A member of the UDP-glycosyltransferase protein family, UGT2A2 is reported to be a UDP-glucuronosyltransferase (UGT) that catalyzes phase II biotransformation reactions in which lipophilic substrates are conjugated with glucuronic acid to increase the metabolite's water solubility, thereby facilitating excretion into either the urine or bile. Post-translational modifications have been described, including glycosylation. Synonyms for this target antigen include UDP-glucuronosyltransferase 2A2 and UDP glucuronosyltransferase 2 family, polypeptide A2. Indicated applications for UGT2A2 antibodies listed below include Western Blot and Immunohistochemistry.